Rejuvenating aging
What anti-aging company Juvenescence plans to do with its series A
Anti-aging company Juvenescence Ltd. is hoping to bring a total of 10 candidates from its portfolio companies and academic partnerships into the clinic over the next two years with its recent $50 million series A funding.
Announced on June 11, the oversubscribed financing saw participation from company founders and insiders, as well as undisclosed institutional investors and family offices. ...